Jill Carroll serves as Executive at APPLIED GENETIC TECHNOLOGIES CORP, where they oversee executive responsibilities. Since joining the company, Jill Carroll has executed 16 insider transactions totaling $136.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 21, 2024 involved selling 504,263 shares valued at $35.6M.
Jill Carroll currently holds 1,479,148 shares of APPLIED GENETIC TECHNOLOGIES CORP (AGTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jill Carroll has been a net seller of AGTC stock. They have purchased $32.7M and sold $103.3M worth of shares.
Jill Carroll's most recent insider trade was on Mar 21, 2024, when they sold 504,263 shares at $70.55 per share.
Get notified when new Form 4 filings are submitted
| $49.13 |
| Discretionary |
| Jun 1, 2023 | ACLX | $1.1M | Sale | 25,556 | $44.35 | Discretionary |
| May 31, 2023 | ACLX | $13.1M | Sale | 315,164 | $41.50 | Discretionary |
| May 11, 2023 | ACLX | $299.3K | Sale | 6,485 | $46.15 | Discretionary |
| May 11, 2023 | ACLX | $28.4M | Sale | 631,932 | $45.00 | Discretionary |
| Feb 8, 2022 | ACLX | $1.0M | Purchase | 66,667 | $15.00 | Discretionary |
| Feb 8, 2022 | ACLX | $0 | Conversion | 3,400,144 | $N/A | Discretionary |
| Feb 8, 2022 | ACLX | $24.0M | Purchase | 1,600,000 | $15.00 | Discretionary |
| Feb 8, 2022 | ACLX | $0 | Conversion | 433,196 | $N/A | Discretionary |
| Apr 1, 2021 | PAND | $340.5M | Tender | 5,674,221 | $60.00 | Discretionary |
| Jul 21, 2020 | PAND | $6.5M | Purchase | 361,111 | $18.00 | Discretionary |
| Jul 21, 2020 | PAND | $0 | Conversion | 348,469 | $N/A | Discretionary |
| Jul 21, 2020 | PAND | $0 | Conversion | 1,538,724 | $N/A | Discretionary |
| Apr 1, 2014 | AGTC | $0 | Conversion | 1,885,836 | $N/A | Discretionary |
| Apr 1, 2014 | AGTC | $1.2M | Purchase | 103,762 | $12.00 | Discretionary |